MINNEAPOLIS (WCCO)-- Mayo Clinic is releasing pre-published data that it says confirms the critical role masks play in preventing COVID-19 infection. On Tuesday, the Mayo Clinic said it is releasing ...

Rochester, Md.-based Mayo Clinic has announced a partnership with leading pharmaceutical manufacturer Baxter and the biotech arm of Velocity Pharmaceutical Development, a bioscience development firm ...

Sep. 15—ROCHESTER — A new study from Mayo Clinic researchers investigates the causes of heart attacks in people younger than age 65. "Understanding why a heart attack happened is just as important as ...

ROCHESTER — A recently published Mayo Clinic study evaluates how caring for a child, spouse or aging parent affects menopause symptoms. "The average age of menopause in our country is 51 to 52 years," ...

The platform will provide secure, decentralized data capture, document management, study monitoring and electronic consent for the clinical trial, according to the tech company's announcement. Mayo ...

InSitu Biologics is a biotech company focused on the development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection. Among its products is ...

ROCHESTER — Mayo Clinic officially opened its new $120 million Anna-Maria and Stephen Kellen Building, locally known as the “Rollercoaster” for its unique exterior design, this week with scientists ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Covid-19 created a shift in the delivery of clinical trials, allowing for participants to access trials outside of a traditional research site, thus expanding the scope of clinical trials. That was ...

ROCHESTER – Mayo Clinic's newest cancer research facility is about to start work. The first wave of researchers are expected to move into the Anna-Maria and Stephen Kellen Building in downtown ...

A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results that give zero guidance to patients on whether they are at elevated risk.

Mayo Clinic will go out-of-network next year for most Medicare Advantage plans from two of the nation's largest health insurers. The changes, which UnitedHealthcare and Humana confirmed over the past ...